HiFiBiO - About the company
HiFiBiO is a series D company based in Paris (France), founded in 2013 by . It operates as a Provider of a technology platform for the discovery of antibody-based drugs. HiFiBiO has raised $180M in funding from investors like , IDG Capital and LYFE Capital. The company has 2318 active competitors, including 598 funded and 400 that have exited. Its top competitors include companies like Amyris, Avidity Biosciences and Sutro Biopharma.
Company Details
Provider of a technology platform for the discovery of antibody-based drugs. The platform combines high throughput, single-cell, functional-based screening of entire B cell (Ab producing cells) populations with next-generation sequencing and rapid DNA synthesis for rare antibody drugs.
- Website
- Social
Key Metrics
Founded Year
2013
Location
Paris, France
Stage
Series D
Total Funding
in 4 rounds
Latest Funding Round
Investors
& 20 more
Ranked
74th among 2318 active competitors
Similar Companies
Amyris &
Get your free copy of HiFiBiO's company profile
HiFiBiO's funding and investors
HiFiBiO has raised a total funding of $180M over 4 rounds. Its latest funding round was a Series D round on Jun 14, 2021 for $75M. 11 investors participated in its latest round, which includes Maison Capital, Fong Capital Partners, and HKSTP.
HiFiBiO has 21 institutional investors including , IDG Capital and LYFE Capital.
Here is the list of recent funding rounds of HiFiBiO:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Jun 14, 2021 | $75M | Series D | 6713257 | 6945729 | |
Aug 28, 2019 | $67M | Series C | 3450010 | 1607756 | IDG Capital, Sequoia Capital, and |
May 16, 2018 | $37.5M | Series B | 6061287 | 2539294 | , LYFE Capital, and |
View details of HiFiBiO's funding rounds and investors
HiFiBiO's founders and board of directors
The founders of HiFiBiO is . and are the CEO of HiFiBiO.
View details of HiFiBiO's Founder profiles and Board Members
HiFiBiO's Competitors and alternates
Top competitors of HiFiBiO include Amyris, Avidity Biosciences and Sutro Biopharma. Here is the list of Top 10 competitors of HiFiBiO, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | , Ìý&²¹³¾±è;Ìý | 80/100 |
2nd | ![]() Avidity Biosciences 2012, San Diego (United States), Public | Develops antibody-siRNA complexes to treat cancer | $143M | Logos, Moore Venture PartnersÌý&²¹³¾±è;Ìý | 74/100 |
3rd | Sutro Biopharma 2003, San Francisco (United States), Public | Developer of antibody-based therapeutics for cancer therapy | $175M | Lilly Ventures, Samsara BioCapitalÌý&²¹³¾±è;Ìý | 73/100 |
4th | Metabolon 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $181M | , East West BankÌý&²¹³¾±è;Ìý | 73/100 |
5th | Arbor Biotechnologies 2016, Cambridge (United States), Series C | Provider of genomic technologies and drug discovery platform | $304M | Logos, ArrowMark PartnersÌý&²¹³¾±è;Ìý | 73/100 |
6th | Univercells 2013, Charleroi (Belgium), Series D | Provider of biomanufacturing technology services for biopharma sector | $151M | In-Q-Tel, European Investment BankÌý&²¹³¾±è;Ìý | 71/100 |
7th | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | Frazier Life Sciences, LogosÌý&²¹³¾±è;Ìý | 71/100 |
8th | ![]() Vividion Therapeutics 2016, Oceanside (United States), Acquired | Developing novel drugs based on a proteome-wide ligand and target discovery platform | $271M | RA Capital Management, Nextech InvestÌý&²¹³¾±è;Ìý | 71/100 |
9th | ![]() Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | Mission Bay Capital, Mission BioCapitalÌý&²¹³¾±è;Ìý | 71/100 |
10th | Relay Therapeutics 2016, Cambridge (United States), Public | Developer of drug discovery platform and study protein motion | $520M | HTIF, BB BiotechÌý&²¹³¾±è;Ìý | 70/100 |
74th | 2013, Paris (France), Series D | Provider of a technology platform for the discovery of antibody-based drugs | $180M | Maison Capital, Fong Capital PartnersÌý&²¹³¾±è;Ìý | 54/100 |
Looking for more details on HiFiBiO's competitors? Click to see the top ones
HiFiBiO's Investments and acquisitions
HiFiBiO has made no investments or acquisitions yet.
Reports related to HiFiBiO
Here is the latest report on HiFiBiO's sector:
View
News related to HiFiBiO
Media has covered HiFiBiO for 1 event in last 1 year.
•
Business Wire•Nov 04, 2024•HiFiBiO
•
Business Wire•Aug 28, 2023•HiFiBiO
•
Business Wire•Jun 23, 2023•HiFiBiO
•
AZoM•Apr 06, 2023•, HiFiBiO
•
ACROFAN•Jan 06, 2023•HiFiBiO
•
•
•
•
•
Frequently asked questions about HiFiBiO
When was HiFiBiO founded?
HiFiBiO was founded in 2013.Where is HiFiBiO located?
HiFiBiO is located in Paris, France.When was the latest funding round of HiFiBiO?
HiFiBiO's latest funding round was on Jun 14, 2021.What is the annual revenue of HiFiBiO?
Annual revenue of HiFiBiO is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Robin the Robot - Glendale based, 2017 founded, Funding Raised company
- Ecarium Clinic - Ukraine based, 2023 founded, Unfunded company
- Cal-Maine Foods - Jackson based, 1996 founded, Public company
- Eka Life - Mumbai based, 1905 founded, Unfunded company
- Taffstyle - Crimmitschau based, 2010 founded, Unfunded company
- Concierge Club - Greece based, Unfunded company